Foghorn Therapeutics FHTX
NASDAQ FHTX
$2.07 -0.85 (-29.11%)
As of: Oct 2, 2026 · 3:47 PM EDT

Foghorn Therapeutics (FHTX) Return on Capital Employed [ROCE] (2020 - 2026)

Updated

Foghorn Therapeutics (FHTX) posted Return on Capital Employed [ROCE] of -44.86% for Q2 2026, up 10.93 percentage points from -55.79% a year earlier and up 13.50 percentage points from the prior quarter.

Analysis

Foghorn Therapeutics (FHTX) Return on Capital Employed [ROCE] (2020 - 2026) Analysis & Trends

For FY2025, Foghorn Therapeutics' Return on Capital Employed [ROCE] came in at -47.65%, down 0.54 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has declined for three consecutive years, though with a five-year change of +9.40 percentage points (FY2020 to FY2025).
  • In prior years, Foghorn Therapeutics' Return on Capital Employed [ROCE] was -47.11% in FY2024 (-9.51 pp), -37.60% in FY2023 (-8.83 pp), -28.77% in FY2022 (+0.94 pp) and -29.72% in FY2021 (+27.34 pp).
  • The Q2 2026 figure stands as the highest quarterly Return on Capital Employed [ROCE] since Q4 2024.
  • On a year-over-year basis, Return on Capital Employed [ROCE] increased in two of the last eight quarters, with an average year-over-year change of -7.07 percentage points.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q3 2022, with a gain of 23.44 percentage points; the weakest was Q3 2025, with a drop of 26.49 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -58.36% (Q1 2026), -60.93% (Q4 2025) and -66.29% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 17.83%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 17.92%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 6.28%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 19.32%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.54%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 16.66%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -5.97%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 11.86%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 20.76%
10 Foghorn Therapeutics 209.61 Mn -116.34 Mn - -44.86%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -44.86%
Mar 31, 2026 -58.36%
Dec 31, 2025 -60.93%
Sep 30, 2025 -66.29%
Jun 30, 2025 -55.79%
Mar 31, 2025 -48.69%
Dec 31, 2024 -44.80%
Sep 30, 2024 -39.80%
Jun 30, 2024 -40.41%
Mar 31, 2024 -47.06%
Dec 31, 2023 -44.73%
Sep 30, 2023 -41.65%
Jun 30, 2023 -41.89%
Mar 31, 2023 -36.82%
Dec 31, 2022 -32.16%
Sep 30, 2022 -29.04%
Jun 30, 2022 -26.22%
Mar 31, 2022 -23.13%
Dec 31, 2021 -33.11%
Sep 30, 2021 -52.49%
API Access

Foghorn Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=FHTX&period=max&api_key=YOUR_API_KEY